Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
Bradner, J. E., R. Mak, S. K. Tanguturi, R. Mazitschek, S. J. Haggarty, K. Ross, C. Y. Chang, et al. 2010. “Chemical Genetic Strategy Identifies Histone Deacetylase 1 (HDAC1) and HDAC2 As Therapeutic Targets in Sickle Cell Disease”. Proc Natl Acad Sci U S A 107: 12617-22.